copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
CAMZYOS® (mavacamten) Patient Site CAMZYOS is a prescription medicine used to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) CAMZYOS may improve your symptoms and your ability to be active It is not known if CAMZYOS is safe and effective in children
About CAMZYOS® (mavacamten) - Symptomatic Obstructive HCM Treatment What Is CAMZYOS ®? CAMZYOS is approved for adults 18 and older It is not known if CAMZYOS is safe and effective in children CAMZYOS is a first-in-class treatment* that helps improve your symptoms and your ability to be active *CAMZYOS is the first FDA-approved cardiac myosin inhibitor
Safety and Side Effects - Rx CAMZYOS® (mavacamten) Because of the serious risk of heart failure, CAMZYOS is only available through a restricted program called the CAMZYOS Risk Evaluation and Mitigation Strategy (REMS) Program
Get CAMZYOS® (mavacamten) oHCM Clinical Study Results - Rx CAMZYOS® What did the study look at? How well CAMZYOS was able to improve symptoms and the ability to be active Patients could achieve either less symptoms (improvement in NYHA Class) and improved pVO 2 by at least 1 5 mL kg min OR symptoms remaining the same and improved pVO 2 by at least 3 0 mL kg min
CAMZYOS® REMS Program - Rx CAMZYOS® (mavacamten) Because of the serious risk of heart failure, CAMZYOS is only available through a restricted program called the CAMZYOS Risk Evaluation and Mitigation Strategy (REMS) Program
Talking to Your Doctor - Rx CAMZYOS® (mavacamten) Because of the serious risk of heart failure, CAMZYOS is only available through a restricted program called the CAMZYOS Risk Evaluation and Mitigation Strategy (REMS) Program